Filter the drugs by their COVID-19 status ,phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance COVID-19 status Phase of research  How it helps Latest publication
MXB-9
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/31/2021
(1,3-Dimethylpyrazol-4-yl)-[4-(4-fluorophenyl)piperazin-1-yl]methanone
Potential treatment - theoretical effect Experimental Antiviral Oct/23/2020
N-[(1R)-2-[4-(1-Methylpiperidin-4-yl)piperazin-1-yl]-2-oxo-1-phenylethyl]-1H-indole-6-carboxamide
Approved for COVID-19 treatment (China, India, Russia) Experimental Antiviral Sep/18/2020
N-({(2S)-1-[(3R)-3-Amino-4-(2-fluorophenyl)butanoyl]pyrrolidin-2-YL}methyl)benzamide
Potential treatment - theoretical effect Experimental Antiviral Sep/18/2020
Berzosertib
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/17/2021
Triazavirin
Potential treatment - clinical evidence Experimental Antiviral Sep/08/2020
Ferroquine
Potential treatment - pre-clinical evidence Experimental Antiviral Sep/08/2020
ZINC104875569
Potential treatment - theoretical effect Experimental Antiviral Feb/08/2021
Celgosivir
Potential treatment - pre-clinical evidence Experimental Antiviral Sep/26/2020
Xuanfei Baidu decoction
Potential treatment - clinical evidence Experimental Unknown Oct/21/2020
MXB-4
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/31/2021
Autologous conditioned serum
Potential treatment - clinical evidence Experimental Other treatment Aug/20/2020
mAb Beta-27
Potential treatment - pre-clinical evidence Experimental Antiviral Nov/27/2021
mAb Beta-47
Potential treatment - pre-clinical evidence Experimental Antiviral Jan/04/2022
Isocyclosporin A
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/23/2021
1-(2-Naphthylmethyl)-2,3-dioxo-indoline-5-carboxamide
Potential treatment - theoretical effect Experimental Antiviral Aug/01/2020
Lifirafenib
Potential treatment - theoretical effect Experimental Antiviral Aug/11/2020
Radotinib
Potential treatment - theoretical effect Experimental Antiviral Aug/11/2020
Ramipril benzyl ester
Potential treatment - theoretical effect Experimental Antiviral Oct/06/2020
Cyclosporin B
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/23/2021